Mobile health intervention for skin cancer prevention among Hispanics
Official title: Developing and Testing a Mobile Health Intervention to Promote Sun Protection Behaviors and Skin Examination Among Hispanics
Run by Rutgers, The State University of New Jersey · NCT05389332 · Data updated 2026-11-12
This study is testing a mobile health program using WhatsApp to see if it can help Hispanic people adopt better sun protection habits to prevent skin cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 114 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | April 20, 2025 |
| Main results expected | October 31, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT05389332 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Hispanic individuals aged 18 and older who have multiple skin cancer risk factors and do not engage in sufficient sun protection behaviors.
✕Probably not a fit
Patients currently being treated for melanoma or nonmelanoma skin cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention aims to develop and evaluate a mobile health program using WhatsApp to promote skin cancer risk-reduction behaviors among Hispanic individuals. The study will gather insights from key stakeholders and community members to ensure the intervention is culturally relevant and effective. Participants will be assessed for their engagement and satisfaction with the intervention, as well as changes in their sun protection behaviors over three and six months. The findings will inform future pilot studies and potential refinements to the intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve skin cancer prevention behaviors among Hispanic populations at risk.
How similar studies have gone: Other studies have shown success with mobile health interventions targeting preventive behaviors, suggesting a promising approach for this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-report as Hispanics * 18 years or older * No personal history of skin cancer * Report more than one skin cancer risk factor * Do not engage in sufficient sun protection behaviors * Have not conducted a SSE in the past three months * Own a smartphone and will be willing to use WhatsApp Exclusion Criteria: * Currently being treated for melanoma or nonmelanoma skin cancer
Where it's running
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Zhaomeng Niu, PhD — Rutgers Cancer Institute of New Jersey
- Study coordinator: Zhaomeng Niu, PhD
- Email: zhaomeng.niu@rutgers.edu
- Phone: 509-339-3076
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based precision oncology clinical trial matching and registry
This study is testing whether an AI tool can help match cancer patients with the right clinical trials based on their specific cancer details to see if it improves their chances of getting into trials and their overall outcomes.
-
Mobile sun protection support to help young adults stay safe in the sun
This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.
-
Psycho-physiological profiling of people with low versus high heat resilience
This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.
-
Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers
This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.
-
First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia
This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.
-
Optical and multi-modal analysis to help diagnose skin cancer
This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.